Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Novel MS Drugs Advance
Hydroxycarboxylic acid receptor 2 mediates dimethyl fumarate's protective effect in EAE.
Covis Pharma to Acquire U.S. Rights from Sanofi for Nilandron®, Plaquenil®, Rilutek®, Uroxatral®, and Kayexalate®
Siponimod (BAF312) for the Treatment of Secondary Progressive Multiple Sclerosis: Design of the Phase 3 EXPAND Trial
Urinary incontinence in multiple sclerosis: prevalence, severity and impact on patients' quality of life.
From High- to Low-Frequency Administered Interferon-Beta for Multiple Sclerosis: A Multicenter Study.
Epidemiology of Multiple Sclerosis: From Risk Factors to Prevention-An Update.
Internal Jugular Vein Cross-Sectional Area and Cerebrospinal Fluid Pulsatility in the Aqueduct of Sylvius: A Comparative Study between Healthy Subjects and Multiple Sclerosis Patients.
Serum IL-33 levels and skin mRNA expression in Behçet's disease.
Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand.
Optical Coherence Tomography in Multiple Sclerosis.
Association between beta-interferon exposure and hospital events in multiple sclerosis.
The Australian Multiple Sclerosis (MS) Immunotherapy Study: A Prospective, Multicentre Study of Drug Utilisation Using the MSBase Platform.
Contribution of different relapse phenotypes to disability in multiple sclerosis.
Clinical efficacy of BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: subgroup analyses of the CONFIRM study.
Immunosuppressive therapy reduces axonal damage in progressive multiple sclerosis.
Effect of smoking on multiple sclerosis: a meta-analysis.
Population pharmacokinetics of ponesimod and its primary metabolites in healthy and organ-impaired subjects.
Extended interval dosing of natalizumab in multiple sclerosis.
Development of a Bilingual MS-Specific Health Classification System: The Preference-Based Multiple Sclerosis Index.
Keystone Symposium: Innate Immunity and Determinants of Microbial Pathogenesis - joint with - Mechanisms of Pro-Inflammatory Diseases
Effects of fumarates on circulating and CNS myeloid cells in multiple sclerosis.
8th World Congress on Controversies in Neurology (CONy)
Neuroimmunology: Phase II trial demonstrates efficacy of erythropoietin in optic neuritis.
Mutation Analysis of Gap Junction Protein Beta 1 and Genotype-Phenotype Correlation in X-linked Charcot-Marie-Tooth Disease in Chinese Patients.

Pages